ExoticRx · exoticrx.com/drugs/voriconazole
US brand names:Vfend
Voriconazole is dosed at 10 mg/kg PO q24h in guinea pigs, per Chandrasekar P, Cutright J, Manavathu E. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model. J Antimicrob Chemother. 2000;45:673-676. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.774 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). Verify against current literature before clinical use.
Inhibits fungal CYP51 (lanosterol 14-alpha-demethylase), blocking ergosterol synthesis. Broader spectrum than fluconazole including Aspergillus.
Drug of choice for aspergillosis. Hepatotoxic — monitor liver enzymes. Many CYP-mediated drug interactions. Visual disturbances in humans. Non-linear pharmacokinetics in some species.
Species references:All Amazon Parrot drugsAll Bearded Dragon drugsAll Chicken (Poultry) drugsAll Dog (Domestic) drugsAll Domestic Pigeon drugsAll Guinea Pig drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 9 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 3–4 mg/kg | q12h | Moderate | Graupmann-Kuzma A, Valentine BA, Shubitz LF, Dial SM, Watrous B, Tornquist SJ. Coccidioidomycosis in dogs and cats: A review. J Am Anim Hosp Assoc. 2008;44:226-235. doi:10.5326/0440226 — Plumb's 10th ed printed p.1314, Voriconazole monograph spanning p.1314-1316. | ORIGINAL SOURCE THE BOOK CITES (2026-08-20): the dose row carries superscript 14 — "3), 2.5 - 3.3 mg/kg Storage/Stability PO every 12 hours14" — which resolves in the monograph's own reference list to: Bray RN, Raghu CL, Leuin AS, Barry-Heffernan CA, Pritchard JC. Oral administration of voriconazole with surgical fungal plaque debridement for the treatment of sinonasal aspergillosis with cribriform plate lysis in three dogs. J Am Vet Med Assoc. 2020;256(1):111-116. This records what the handbook attributes the figure to. It is NOT a statement that the reference was read or that it validates the dose. |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.